View in EDS

Cell-cycle targeted cancer therapy: clinical advances, biological gaps, and the emergence of selective CDK4 inhibitors.

Saved in:
Bibliographic Details
Title: Cell-cycle targeted cancer therapy: clinical advances, biological gaps, and the emergence of selective CDK4 inhibitors.
Authors: Safaroghli-Azar A; Drug Discovery and Development, School of Pharmacy and Biomedical Science, College of Health, Adelaide University, Adelaide, 5001, SA, Australia., Mekonnen LB; Drug Discovery and Development, School of Pharmacy and Biomedical Science, College of Health, Adelaide University, Adelaide, 5001, SA, Australia., Lenjisa J; Drug Discovery and Development, School of Pharmacy and Biomedical Science, College of Health, Adelaide University, Adelaide, 5001, SA, Australia., Milne R; Drug Discovery and Development, School of Pharmacy and Biomedical Science, College of Health, Adelaide University, Adelaide, 5001, SA, Australia., Wang S; Drug Discovery and Development, School of Pharmacy and Biomedical Science, College of Health, Adelaide University, Adelaide, 5001, SA, Australia. shudong.wang@adelaide.edu.au.
Source: Journal of hematology & oncology [J Hematol Oncol] 2026 Apr 06; Vol. 19 (1). Date of Electronic Publication: 2026 Apr 06.
Publication Type: Journal Article; Review
Journal Info: Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722 (Electronic) Linking ISSN: 17568722 NLM ISO Abbreviation: J Hematol Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41943159
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Cell-cycle targeted cancer therapy: clinical advances, biological gaps, and the emergence of selective CDK4 inhibitors.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Safaroghli-Azar+A%22">Safaroghli-Azar A</searchLink>; Drug Discovery and Development, School of Pharmacy and Biomedical Science, College of Health, Adelaide University, Adelaide, 5001, SA, Australia.<br /><searchLink fieldCode="AU" term="%22Mekonnen+LB%22">Mekonnen LB</searchLink>; Drug Discovery and Development, School of Pharmacy and Biomedical Science, College of Health, Adelaide University, Adelaide, 5001, SA, Australia.<br /><searchLink fieldCode="AU" term="%22Lenjisa+J%22">Lenjisa J</searchLink>; Drug Discovery and Development, School of Pharmacy and Biomedical Science, College of Health, Adelaide University, Adelaide, 5001, SA, Australia.<br /><searchLink fieldCode="AU" term="%22Milne+R%22">Milne R</searchLink>; Drug Discovery and Development, School of Pharmacy and Biomedical Science, College of Health, Adelaide University, Adelaide, 5001, SA, Australia.<br /><searchLink fieldCode="AU" term="%22Wang+S%22">Wang S</searchLink>; Drug Discovery and Development, School of Pharmacy and Biomedical Science, College of Health, Adelaide University, Adelaide, 5001, SA, Australia. shudong.wang@adelaide.edu.au.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101468937%22">Journal of hematology & oncology</searchLink> [J Hematol Oncol] 2026 Apr 06; Vol. 19 (1). <i>Date of Electronic Publication: </i>2026 Apr 06.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Biomed+Central%22">Biomed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101468937 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1756-8722 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217568722%22">17568722 </searchLink><i>NLM ISO Abbreviation: </i>J Hematol Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41943159
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s13045-026-01794-7
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Cell-cycle targeted cancer therapy: clinical advances, biological gaps, and the emergence of selective CDK4 inhibitors.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Safaroghli-Azar A
      – PersonEntity:
          Name:
            NameFull: Mekonnen LB
      – PersonEntity:
          Name:
            NameFull: Lenjisa J
      – PersonEntity:
          Name:
            NameFull: Milne R
      – PersonEntity:
          Name:
            NameFull: Wang S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 06
              M: 04
              Text: 2026 Apr 06
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1756-8722
          Numbering:
            – Type: volume
              Value: 19
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Journal of hematology & oncology
              Type: main
ResultId 1